The ocular surface hosts a low-abundance microbial community that may help regulate immune defenses, while changes in its ...

New Delhi: Infections that once responded to commonly prescribed antibiotics may now require stronger medicines or ...

Japanese researchers used whole-genome sequencing to identify a new mycobacterial species, Mycobacterium meguroense, causing lung disease in a cord blood transplant recipient.

Armata Pharma strengthens IP portfolio with two recent patent issuances in the US: Los Angeles Thursday, October 8, 2026, 16:00 Hrs [IST] Armata Pharmaceuticals, Inc., a late clin ...

Pseudomonas aeruginosa is a common culprit in hospital-acquired bacterial infections and is growing more resistant to ...

A joint research team has identified a new mechanism underlying antibiotic resistance in Pseudomonas aeruginosa, a major ...

Liquid chromatography-high resolution mass spectrometry (LC-HRMS) identifies over 700 contaminants and antimicrobial ...

Issued patents provide intellectual property protection for clinical candidates, AP-SA02 and AP-PA02, until at least 2041. LOS ANGELES, Oct. 7, 2026 // -- Armata Pharmac ...

Armata Pharmaceuticals, Inc. announced issuance of two patents by the United States Patent and Trademark Office ("USPTO") covering its bacteriophage programs, AP-SA02 and AP-PA02. These newly issued U ...

Issuedpatents provide intellectual property protection for clinical candidates, AP-SA02 and AP-PA02, until at least 2041LOS ANGELES, Oct. 7, 2026 /PRNewswire/ ...

A joint research team led by Professor Hongbaek Cho of the Department of Biological Sciences at Sungkyunkwan University (SKKU) and Professor Jeong Min Chung of the Department of Biotechnology at The ...